Saccharomyces cerevisiae (baker
There is no firm epidemiological or experimental evidence that directly links diet and Crohn's disease, although the results of dietary surveys' and the as yet unconfirmed therapeutic value of 'exclusion diets'23 suggest that dietary factors may precipitate or perpetuate acute exacerbations in some patients with this disorder.
A local intestinal immune response to as yet unidentified antigen(s) resulting in tissue damage and granuloma formation has been suggested as a possible mechanism of tissue injury in Crohn's disease. Both dietary and bacterial antigens have been implicated. Thus circulating antibodies to various dietary and bacterial antigens have been described in patients with inflammatory bowel disease5-' as well as in coeliac disease. '°A recent report suggested that milk may be an 'aetiologic factor' in a patient with Crohn's ileitis."`Main et al '2 showed that IgG and IgA antibodies to Saccharomyces cerevisiae (baker's yeast) are present in high titres in patients with Crohn's disease but not in those with ulcerative colitis or normal control subjects. Thus, they claimed that yeasts may be aetiologically relevant in some patients with Crohn's disease.
In view of the unconfirmed pathological importance of yeast antibodies in Crohn's disease, this study was designed to examine the prevalence and possible pathogenic significance of IgG and IgA antibodies specific to S cerevisiae in patients with Crohn's disease and ulcerative colitis using patients with coeliac disease and healthy subjects as controls.
Patients and methods

PATIENTS
Forty nine patients with Crohn's disease were studied. There were 21 men and 28 women with a mean age of 45 years (range of antigen suspension per well and incubated at 37°C for 60 minutes and at 4°C for 16 hours. Each well was then washed four times with 0.05 M phosphate buffered saline, pH 7.3, to which 0.01% (v/v) Triton X-100 was added (PBS-T). Test sera were diluted 1:100 using PBS-T to which 1% (w) bovine serum albumin was added (PBS-T-BSA). Each serum sample was tested in duplicate. A 100 itl aliquot of serum was added to each antigen coated well. In addition to test sera, each plate included a positive and a negative reference serum and a negative control where no serum was added. The plates were then incubated at 37°C for 60 minutes and washed four times with PBS-T. A 100 ,ul aliquot of affinity purified alkaline phosphatase conjugated antihuman IgG or IgA (Sigma, Poole, Dorset) diluted 1:400 in PBS-T-BSA was added to each well and the incubation and washing steps were repeated.
One hundred 1d of a 2 mg/ml solution of P-nitrophenyl phosphate (Sigma) in 0.05 M glycine-sodium hydroxide buffer pH 10-2, were then added to each well. The plates were incubated at 37°C for 30-40 minutes until the optical density of the positive reference serum reached the predetermined value of 1-0 at 410 nm, at which time the optical densities of the test sera were read (Microelisa Minireader MR590, Guernsey, Channel Islands, UK). Thus the quantities of IgG and IgA anti-yeast antibodies were expressed as optical density measurements in relation to the reference positive serum.
STATISTICAL ANALYSIS
Data were expressed as mean (SEM). The MannWhitney U test was used to examine the significances in the differences in antibody levels between study groups. Intercorrelation between IgG and IgA antibodies to various S cerevisiae strains were tested using Spearman's equation.
Results Figure 1 (A, B, and C) 
